Amrize (NYSE:AMRZ) Shares Gap Down After Earnings Miss

Amrize Ltd (NYSE:AMRZGet Free Report)’s share price gapped down prior to trading on Friday following a dissappointing earnings announcement. The stock had previously closed at $51.22, but opened at $47.50. Amrize shares last traded at $47.6760, with a volume of 1,364,674 shares traded.

The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). The company had revenue of $3.49 billion during the quarter. Amrize had a return on equity of 9.84% and a net margin of 9.70%.

Amrize Cuts Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were issued a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize’s dividend payout ratio (DPR) is 21.05%.

Key Stories Impacting Amrize

Here are the key news stories impacting Amrize this week:

  • Positive Sentiment: Amrize reported second-quarter revenue of $3.49 billion, up 8.6% year over year, while net income increased 14.4% to $476 million. Growth was supported by demand from data centers, energy projects, manufacturing plants and infrastructure modernization. Amrize Reports Second Quarter 2026 Results
  • Positive Sentiment: The company raised its 2026 revenue outlook to $12.5 billion-$12.7 billion, above the roughly $12.4 billion analyst consensus, and forecast adjusted EBITDA of $3.1 billion-$3.2 billion. Amrize Lifts 2026 Revenue Outlook
  • Positive Sentiment: Amrize declared a quarterly dividend of $0.11 per share, payable August 26, and returned $502 million to shareholders through dividends and share repurchases during the quarter. Amrize Declares Dividend
  • Neutral Sentiment: Quarterly earnings grew from the prior year, with reported EPS of $0.88 versus $0.78 a year earlier, but the comparison includes differing estimates and reported diluted-EPS figures across company and data-provider disclosures.
  • Negative Sentiment: Reported EPS of $0.88 missed the $0.92 consensus estimate, making the earnings shortfall the clearest near-term reason for investor disappointment. Amrize Misses Q2 Earnings Estimates
  • Negative Sentiment: Higher fuel, freight and other operating costs limited adjusted EBITDA growth to 5.8% and pressured margins despite stronger sales, raising concerns about cost inflation and profit conversion.

Wall Street Analysts Forecast Growth

Several research firms have commented on AMRZ. Oppenheimer decreased their target price on shares of Amrize from $68.00 to $65.00 and set an “outperform” rating for the company in a research report on Tuesday, July 21st. Morgan Stanley set a $63.00 price objective on Amrize and gave the stock an “overweight” rating in a report on Monday, June 22nd. Royal Bank Of Canada cut their target price on Amrize from $61.00 to $60.00 and set a “sector perform” rating on the stock in a research note on Friday, May 1st. Citigroup reduced their price target on Amrize from $76.00 to $66.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Amrize in a report on Friday, June 26th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $62.79.

Read Our Latest Stock Report on AMRZ

Insider Activity at Amrize

In other news, insider Nollaig Forrest bought 2,000 shares of the stock in a transaction on Friday, May 22nd. The shares were purchased at an average price of $50.25 per share, for a total transaction of $100,500.00. Following the completion of the purchase, the insider directly owned 20,139 shares of the company’s stock, valued at $1,011,984.75. This trade represents a 11.03% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CTO Roald Brouwer purchased 1,500 shares of the business’s stock in a transaction dated Thursday, May 21st. The shares were acquired at an average price of $49.84 per share, for a total transaction of $74,760.00. Following the acquisition, the chief technology officer directly owned 19,757 shares in the company, valued at $984,688.88. This represents a 8.22% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders have acquired 54,918 shares of company stock valued at $2,717,324. Insiders own 0.54% of the company’s stock.

Institutional Trading of Amrize

Several large investors have recently modified their holdings of AMRZ. MCF Advisors LLC acquired a new position in Amrize during the 4th quarter worth $27,000. Basepoint Wealth LLC bought a new position in shares of Amrize in the fourth quarter worth about $33,000. Laurel Wealth Advisors LLC bought a new stake in Amrize during the 4th quarter valued at approximately $34,000. US Bancorp DE acquired a new stake in Amrize in the 3rd quarter valued at approximately $38,000. Finally, Itau Unibanco Holding S.A. increased its position in Amrize by 150.0% in the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock worth $41,000 after buying an additional 450 shares during the period.

Amrize Trading Down 7.3%

The company has a market capitalization of $26.25 billion, a P/E ratio of 22.71, a P/E/G ratio of 1.12 and a beta of 0.11. The company has a 50-day simple moving average of $52.09 and a 200 day simple moving average of $54.78. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40.

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Articles

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.